Drug Metabolism Reviews

Papers
(The TQCC of Drug Metabolism Reviews is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
The annoying flaws of gerontological research38
Cell-Biomaterial constructs for wound healing and skin regeneration35
Drug transporters in drug disposition – the year 2022 in review29
Enantioselectivity in some physiological and pathophysiological roles of hydroxyeicosatetraenoic acids28
Differential modulation of cytochrome P450 enzymes by arsenicals in non-human experimental models21
An in-depth review of PPARγ modulators as anti-diabetes therapeutics20
New strategy for rational use of antihypertensive drugs in clinical practice in high-altitude hypoxic environments20
Mechanisms of intestinal pharmacokinetic natural product-drug interactions19
Cytochrome P450-mediated carbon-carbon bond formation in drug metabolism18
Assessing and mitigating pH-mediated DDI risks in drug development – formulation approaches and clinical considerations15
Biopolymers as promising vehicles for drug delivery to the brain13
Drug transporters in drug disposition – highlights from the year 202413
Metabolism of new drug modalities research advances – 2024 year in review12
Genetic determinants of paclitaxel-induced peripheral neuropathy: a review of current literature12
Metabolic activation of tyrosine kinase inhibitors: recent advance and further clinical practice12
Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special population12
Scaling factors to inform in vitro - in vivo extrapolation from preclinical and livestock animals: state of the field and recommendations 11
Clinical pharmacokinetics of nebivolol: a systematic review11
A transcriptional regulatory network of HNF4α and HNF1α involved in human diseases and drug metabolism11
Favipiravir, remdesivir, and lopinavir: metabolites, degradation products and their analytical methods9
Effects of intestinal flora on pharmacokinetics and pharmacodynamics of drugs8
Advances in drug resistance of osteosarcoma caused by pregnane X receptor8
In silico ADME and target prediction studies of Alogliptin as drug molecule8
Impact of DNA methylation on ADME gene expression, drug disposition, and efficacy8
0.02269983291626